Figure 1. Diversity of cell types in each sample from ECC patients delineated by single-cell transcriptomic analysis. (A) Experimental workflow of scRNA-seq procedure for ECC tumors and paratumor tissues. (B) Hematoxylin and eosin (HE) staining on paratumor and tumor slides of the 5 ECC patients. Scale bars, 100 mm. (C) Samples obtained from 5 EC patients and clinicopathological characteristics of the 5 patients, more details are provided in